Thank you for your interest in the COMPPARE study.
COMPPARE stands for “A Prospective COMparative Study of Outcomes with Proton and Photon RAdiation in PRostate CancEr (COMPPARE).” This study is funded by the Patient-Centered Outcomes Research Institute (PCORI) and led by Dr. Nancy Mendenhall at the University of Florida.
Over 40 institutions across the country are participating in the COMPPARE study – to find a location near you, view our COMPPARE Consortium map here. You are also welcome to email us for more information.
About the study
COMPPARE will ask 3,000 prostate cancer patients (ages 30-80) across the US who have chosen to be treated with proton therapy or photon therapy to answer brief surveys regarding treatment choice, quality of life, and side effects for at least 3 years.
To participate, talk to your doctor about the study. You can also email firstname.lastname@example.org for any questions you may have.